The Alzheimer’s Assessment is designed to detect early signs of Alzheimer’s disease by measuring levels of phosphorylated Tau217 (p-Tau217)—a key biomarker linked to brain changes that occur well before symptoms appear. Early detection can empower individuals to take proactive steps to slow or prevent cognitive decline. Taking action early is essential for protecting long-term brain health.
This blood test measures the concentration of p-Tau217, a protein strongly associated with Alzheimer’s disease. Elevated levels can indicate early brain changes such as amyloid buildup and neurofibrillary tangles—hallmarks of the disease—often before memory loss or cognitive symptoms become noticeable.
Adults aged 40 and above looking to proactively protect cognitive health Individuals with a family history of Alzheimer’s or dementia-related conditions People noticing memory lapses, reduced attention span, or mental fog Individuals with chronic illnesses such as diabetes or heart disease, which may affect brain function Health-conscious individuals seeking to monitor and maintain brain health
Blood
2–4 weeks
We help you revitalize your body’s natural energy and vitality through scientifically designed health management plans, enabling you to live a healthier and more confident life.
